Rowlandmiller & PARTNERS.ADV Acquires 1,819 Shares of Intuitive Surgical, Inc. $ISRG

Rowlandmiller & PARTNERS.ADV increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 65.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,589 shares of the medical equipment provider’s stock after buying an additional 1,819 shares during the period. Rowlandmiller & PARTNERS.ADV’s holdings in Intuitive Surgical were worth $2,052,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Intuitive Surgical in the second quarter worth about $2,569,260,000. Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 2.1% in the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after purchasing an additional 670,302 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Intuitive Surgical by 20.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after purchasing an additional 566,979 shares during the last quarter. Jennison Associates LLC lifted its holdings in Intuitive Surgical by 20.4% during the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after buying an additional 528,359 shares in the last quarter. Finally, Wellington Management Group LLP boosted its position in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after buying an additional 457,080 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 104 shares of the stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $559.90, for a total value of $58,229.60. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Gary S. Guthart sold 22,806 shares of Intuitive Surgical stock in a transaction on Monday, December 1st. The stock was sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the transaction, the insider directly owned 2,694 shares in the company, valued at approximately $1,537,977.66. This represents a 89.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 109,043 shares of company stock valued at $60,816,225. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 0.9%

Shares of ISRG opened at $542.32 on Monday. The stock has a market cap of $194.41 billion, a P/E ratio of 71.74, a price-to-earnings-growth ratio of 4.98 and a beta of 1.68. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The stock’s 50-day moving average price is $529.62 and its two-hundred day moving average price is $505.36.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the prior year, the business posted $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently commented on ISRG. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Royal Bank Of Canada set a $625.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Daiwa Capital Markets upped their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Mizuho set a $575.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Finally, Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 24th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $608.79.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.